Goldman Sachs’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $333K | Buy |
|
|||||
|
2023
Q4 | $95.1K | Sell |
|
|||||
|
2023
Q3 | $292K | Buy |
|
|||||
|
2023
Q2 | $613K | Buy |
|
|||||
|
2023
Q1 | $778K | Sell |
|
|||||
|
2022
Q4 | $1.91M | Buy |
|
|||||
|
2022
Q3 | $4.36M | Buy |
|
|||||
|
2022
Q2 | $2.21M | Buy |
|
|||||
|
2022
Q1 | $2.5M | Sell |
|
|||||
|
2021
Q4 | $3.66M | Sell |
|
|||||
|
2021
Q3 | $5.29M | Buy |
|
|||||
|
2021
Q2 | $1.14M | Buy |
|
|||||
|
2021
Q1 | $1.49M | Buy |
|
|||||
|
2020
Q4 | $1.45M | Sell |
|
|||||
|
2020
Q3 | $845K | Sell |
|
|||||
|
2020
Q2 | $1.19M | Buy |
|
|||||
|
2020
Q1 | $549K | Sell |
|
|||||
|
2019
Q4 | $1.6M | Buy |
|
|||||
|
2019
Q3 | $755K | Sell |
|
|||||
|
2019
Q2 | $823K | Buy |
|